Volitionrx Ltd
VNRX- Exchange
- NYSE
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000093314
No open-market purchases or sales by Volitionrx Ltd insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $2.61M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Volitionrx Ltd as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- −1 vs. Q3 2021
- Shares held
- 5.95M
- −211.7K (−3.4%) vs. Q3 2021
- Total value
- $18.7M
- −$414.7K (−2.2%) vs. Q3 2021
- New holders
- 3
- 7 more added
- Sold out
- 4
- 12 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VNRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 24 | $2.61M |
| Q1 2026 | 31 | $4.52M |
| Q4 2025 | 28 | $4.13M |
| Q3 2025 | 33 | $17.7M |
| Q2 2025 | 29 | $18.2M |
| Q1 2025 | 25 | $12.0M |
| Q4 2024 | 27 | $11.2M |
| Q3 2024 | 22 | $10.5M |
| Q2 2024 | 27 | $4.84M |
| Q1 2024 | 24 | $5.89M |
| Q4 2023 | 28 | $4.56M |
| Q3 2023 | 30 | $4.35M |
| Q2 2023 | 34 | $8.99M |
| Q1 2023 | 38 | $12.2M |
| Q4 2022 | 34 | $15.1M |
| Q3 2022 | 34 | $8.02M |
| Q2 2022 | 31 | $12.2M |
| Q1 2022 | 34 | $18.3M |
| Q4 2021 | 37 | $18.7M |
| Q3 2021 | 39 | $19.2M |
| Q2 2021 | 47 | $21.4M |
| Q1 2021 | 57 | $33.0M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Volitionrx Ltd; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lagoda Investment Management, L.P. | 3,283,913 | $10.3M | 4.89% | +240,569+7.9% | Added |
| BlackRock Inc. | 542,218 | $1.70M | 0.00% | +4,867+0.9% | Added |
| Vanguard Group Inc | 509,570 | $1.60M | 0.00% | −2,188−0.4% | Reduced |
| Morgan Stanley | 469,553 | $1.48M | 0.00% | −112,956−19.4% | Reduced |
| Geode Capital Management, LLC | 269,487 | $846.0K | 0.00% | −1,333−0.5% | Reduced |
| Bridgeway Capital Management, LLC | 241,100 | $757.0K | 0.01% | −25,000−9.4% | Reduced |
| State Street Corp | 104,823 | $329.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 76,950 | $242.0K | 0.00% | +6,375+9.0% | Added |
| Cowen Prime Advisors LLC | 64,600 | $203.0K | 0.07% | +2,400+3.9% | Added |
| Northern Trust Corp | 63,219 | $199.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 62,622 | $197.0K | 0.00% | −715−1.1% | Reduced |
| Spectrum Asset Management, Inc. (NB/CA) | 55,596 | $175.0K | 0.05% | 00.0% | Unchanged |
| Barclays PLC | 29,539 | $93.0K | 0.00% | +26,379+834.8% | Added |
| Dimensional Fund Advisors LP | 22,385 | $70.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 21,828 | $69.0K | 0.00% | 00.0% | Unchanged |
| Creative Planning | 16,160 | $51.0K | 0.00% | 00.0% | Unchanged |
| Ergoteles LLC | 15,898 | $50.0K | 0.00% | −118,202−88.1% | Reduced |
| Charles Schwab Investment Management Inc | 15,384 | $49.0K | 0.00% | 00.0% | Unchanged |
| Garrison Bradford & Associates Inc | 15,500 | $49.0K | 0.04% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 11,300 | $35.0K | 0.00% | −117,400−91.2% | Reduced |
| Citadel Advisors LLC | 10,938 | $34.0K | 0.00% | −8,137−42.7% | Reduced |
| Simplex Trading, LLC | 8,677 | $27.0K | 0.00% | +7,875+981.9% | Added |
| Captrust Financial Advisors | 6,000 | $19.0K | 0.00% | +6,000 | New |
| Hartford Financial Management Inc. | 5,000 | $16.0K | 0.00% | 00.0% | Unchanged |
| Credit Agricole S A | 4,000 | $13.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,954 | $12.0K | 0.00% | +3,854+3,854.0% | Added |
| Advisor Group Holdings, Inc. | 3,520 | $11.0K | 0.00% | −12,800−78.4% | Reduced |
| Founders Capital Management | 3,000 | $9.00K | 0.01% | 00.0% | Unchanged |
| CarsonAllaria Wealth Management, Ltd. | 2,840 | $9.00K | 0.01% | +2,840 | New |
| UBS Group AG | 1,876 | $6.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1,544 | $5.00K | 0.00% | −1,054−40.6% | Reduced |
| National Bank of Canada | 1,000 | $3.00K | 0.00% | +1,000 | New |
| Total Clarity Wealth Management, Inc. | 720 | $2.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 347 | $1.09K | 0.00% | −46−11.7% | Reduced |
| Wells Fargo & Company | 225 | $1.00K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 150 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 5 | $0 | 0.00% | −26−83.9% | Reduced |
| HRT Financial LP | 0 | $0 | 0.00% | −65,570−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −29,539−100.0% | Sold out |
| MTM Investment Management, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Brewin Dolphin Ltd | 0 | $0 | 0.00% | −8,885−100.0% | Sold out |
| Rinet Co LLC | – | – | – | – | Not filed |